These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 15057660)

  • 1. Charcot-Marie-Tooth disease: electrophysiology, molecular genetics and clinical management.
    Carter GT; England JD; Chance PF
    IDrugs; 2004 Feb; 7(2):151-9. PubMed ID: 15057660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and electrophysiological features in Charcot-Marie-Tooth disease with mutations in the NEFL gene.
    Miltenberger-Miltenyi G; Janecke AR; Wanschitz JV; Timmerman V; Windpassinger C; Auer-Grumbach M; Löscher WN
    Arch Neurol; 2007 Jul; 64(7):966-70. PubMed ID: 17620486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic administration of progesterone antagonist in a model of Charcot-Marie-Tooth disease (CMT-1A).
    Sereda MW; Meyer zu Hörste G; Suter U; Uzma N; Nave KA
    Nat Med; 2003 Dec; 9(12):1533-7. PubMed ID: 14608378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Charcot-Marie-Tooth disease].
    Lee YC; Chang MH; Lin KP
    Acta Neurol Taiwan; 2008 Sep; 17(3):203-13. PubMed ID: 18975529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth disease.
    Passage E; Norreel JC; Noack-Fraissignes P; Sanguedolce V; Pizant J; Thirion X; Robaglia-Schlupp A; Pellissier JF; Fontés M
    Nat Med; 2004 Apr; 10(4):396-401. PubMed ID: 15034573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Schwann cells and the pathogenesis of inherited motor and sensory neuropathies (Charcot-Marie-Tooth disease).
    Berger P; Niemann A; Suter U
    Glia; 2006 Sep; 54(4):243-57. PubMed ID: 16856148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Charcot-Marie-Tooth disease: a clinico-genetic confrontation.
    Barisic N; Claeys KG; Sirotković-Skerlev M; Löfgren A; Nelis E; De Jonghe P; Timmerman V
    Ann Hum Genet; 2008 May; 72(Pt 3):416-41. PubMed ID: 18215208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of disease: inherited demyelinating neuropathies--from basic to clinical research.
    Nave KA; Sereda MW; Ehrenreich H
    Nat Clin Pract Neurol; 2007 Aug; 3(8):453-64. PubMed ID: 17671523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular genetics of inherited neuropathies].
    Takashima H
    Rinsho Shinkeigaku; 2006 Jan; 46(1):1-18. PubMed ID: 16541790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Charcot-Marie-Tooth disease: an overview of genotypes, phenotypes, and clinical management strategies.
    El-Abassi R; England JD; Carter GT
    PM R; 2014 Apr; 6(4):342-55. PubMed ID: 24434692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Charcot-Marie-Tooth disease associated with a pyramidal syndrome: clinical, electrophysiological, and neuropathological study of neuro-muscular biopsies in 14 cases].
    Thiam A; Sene FD; Ndao AK; Ndiaye M; Ndiaye IP
    Dakar Med; 2002; 47(2):182-7. PubMed ID: 15776672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Different phenotypes of Charcot-Marie-Tooth disease caused by mutations in the same gene. Are classical criteria for classification still valid?].
    Sevilla T; Vílchez JJ
    Neurologia; 2004 Jun; 19(5):264-71. PubMed ID: 15150710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Charcot-Marie-tooth disease.
    Casasnovas C; Cano LM; Albertí A; Céspedes M; Rigo G
    Foot Ankle Spec; 2008 Dec; 1(6):350-4. PubMed ID: 19825739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An animal model for Charcot-Marie-Tooth disease type 4B1.
    Bonneick S; Boentert M; Berger P; Atanasoski S; Mantei N; Wessig C; Toyka KV; Young P; Suter U
    Hum Mol Genet; 2005 Dec; 14(23):3685-95. PubMed ID: 16249189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The various Charcot-Marie-Tooth diseases.
    Vallat JM; Mathis S; Funalot B
    Curr Opin Neurol; 2013 Oct; 26(5):473-80. PubMed ID: 23945280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Schwann cell-axon interactions in Charcot-Marie-Tooth disease.
    Griffin JW; Sheikh K
    Ann N Y Acad Sci; 1999 Sep; 883():77-90. PubMed ID: 10586234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early onset neuropathy in a compound form of Charcot-Marie-Tooth disease.
    Meggouh F; de Visser M; Arts WF; De Coo RI; van Schaik IN; Baas F
    Ann Neurol; 2005 Apr; 57(4):589-91. PubMed ID: 15786462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pediatric Charcot-Marie-Tooth disease.
    Jani-Acsadi A; Ounpuu S; Pierz K; Acsadi G
    Pediatr Clin North Am; 2015 Jun; 62(3):767-86. PubMed ID: 26022174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bilateral trigeminal neuralgia and charcot-marie-tooth disease: diagnosis and successful microsurgical treatment of bilateral neurovascular compression.
    Tekkok IH; Sumer M
    Zentralbl Neurochir; 2008 Aug; 69(3):148-51. PubMed ID: 18666057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disruption of neurofilament network with aggregation of light neurofilament protein: a common pathway leading to motor neuron degeneration due to Charcot-Marie-Tooth disease-linked mutations in NFL and HSPB1.
    Zhai J; Lin H; Julien JP; Schlaepfer WW
    Hum Mol Genet; 2007 Dec; 16(24):3103-16. PubMed ID: 17881652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.